45802-700 : Tacrolimus 1 mg/g Topical Ointment


NDC: 45802-700
Labeler: Perrigo New York Inc
Product Type: Human Prescription Drug
Drug Name:  Tacrolimus
Dosage Form: Topical Ointment
Application #: NDA050777
Rev. Date: 


NDC Package Codes:

  • 45802-700-00: 1 TUBE IN 1 CARTON (45802‑700‑00) > 30 G IN 1 TUBE
  • 45802-700-01: 1 TUBE IN 1 CARTON (45802‑700‑01) > 60 G IN 1 TUBE
  • 45802-700-02: 1 TUBE IN 1 CARTON (45802‑700‑02) > 100 G IN 1 TUBE

Active Ingredients:

  • Tacrolimus

Dosage Strength:

  • 1 mg/g

Pharmaceutical Classes:

  • Calcineurin Inhibitor Immunosuppressant [EPC]
  • Calcineurin Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 45802-390 Tacrolimus .3 mg/g Topical Ointment by Perrigo New York Inc
  • 0093-3428 Tacrolimus .3 mg/g Topical Ointment by Teva Pharmaceuticals USA, Inc.
  • 0093-3429 Tacrolimus 1 mg/g Topical Ointment by Teva Pharmaceuticals USA, Inc.
  • 0168-0416 Tacrolimus 1 mg/g Topical Ointment by E. Fougera & Co. a Division of Fougera Pharmaceuticals Inc.
  • 0168-0417 Tacrolimus .3 mg/g Topical Ointment by E. Fougera & Co. a Division of Fougera Pharmaceuticals Inc.
  • 0179-0079 Tacrolimus 1 mg (As Anhydrous Tacrolimus) Oral Capsule by Kaiser Foundation Hospitals
  • 0378-2045 Tacrolimus 0.5 mg (As Anhydrous Tacrolimus) Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-2046 Tacrolimus 1 mg (As Anhydrous Tacrolimus) Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0378-2047 Tacrolimus 5 mg (As Anhydrous Tacrolimus) Oral Capsule by Mylan Pharmaceuticals Inc.
  • 0591-3359 Tacrolimus 5 mg (As Anhydrous Tacrolimus) Oral Capsule by Watson Laboratories, Inc.
  • 0781-2102 Tacrolimus 0.5 mg (As Anhydrous Tacrolimus) Oral Capsule by Sandoz Inc
  • 0781-2103 Tacrolimus 1 mg (As Anhydrous Tacrolimus) Oral Capsule by Sandoz Inc
  • 0781-2104 Tacrolimus 5 mg (As Anhydrous Tacrolimus) Oral Capsule by Sandoz Inc
  • 0781-9302 Tacrolimus 0.5 mg (As Anhydrous Tacrolimus) Oral Capsule by Sandoz Inc
  • 0781-9303 Tacrolimus 1 mg (As Anhydrous Tacrolimus) Oral Capsule by Sandoz Inc
  • 0781-9304 Tacrolimus 5 mg (As Anhydrous Tacrolimus) Oral Capsule by Sandoz Inc
  • 0904-6425 Tacrolimus 1 mg Oral Capsule by Major Pharmaceuticals
  • 0904-6623 Tacrolimus .5 mg Oral Capsule by Major Pharmaceuticals
  • 0904-6624 Tacrolimus 5 mg Oral Capsule by Major Pharmaceuticals
  • 0904-7097 Tacrolimus 1 mg Oral Capsule by Major Pharmaceuticals
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 45802-700 QR Code

< Prev: 45802-680Next: 45802-701 >

Related Discussions:

stopping tacrolimus
Are there any withdrawals or side effects from stopping Tacrolimus? I had a heart tx and I'm still on Rappamune, Cel... 1 reply
Pomegranate interactions with Tacrolimus and Mycophenolate
Can I take a tonic that includes pomegranate supplement when taking Tacrolimus and Mycophenolate anti-kidney-rejection m... 1 reply
Forskolin, Atenolol, Amlodipine, Tacrolimus, Bactrim, Humalog & Cellcept
I had a kidney transplant and am on the following medications: Tacrolimus, cellcept, amlodipine, atenolol, bactrim &... 1 reply
Liver transplant and side effects of Tacrolimus
I am a good friend and caregiver for a man who was given the new gift of life. The down side is the side effects of this...
Tacrolimus Ointment 0 1% w/w
Tacrolimus Ointment 0 1% w/w is help full for depigmentation of skin..??...
tacrolimus assy
please send the tacrolimus assay method for research work...
Tacrolimus assay
Does anyone know how to remove the excipients from tacrolimus prior to running it on HPLC? I have found that susequent r...
tacrolimus
kidney transplant sapresant...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.